关注
Andreas Verras
Andreas Verras
未知所在单位机构
在 schrodinger.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Is multitask deep learning practical for pharma?
B Ramsundar, B Liu, Z Wu, A Verras, M Tudor, RP Sheridan, V Pande
Journal of chemical information and modeling 57 (8), 2068-2076, 2017
2642017
Mutagenesis and functional studies with succinate dehydrogenase inhibitors in the wheat pathogen Mycosphaerella graminicola
G Scalliet, J Bowler, T Luksch, L Kirchhofer-Allan, D Steinhauer, K Ward, ...
PLoS One 7 (4), e35429, 2012
2042012
Microscale high-throughput experimentation as an enabling technology in drug discovery: Application in the discovery of (Piperidinyl) pyridinyl-1 H-benzimidazole diacylglycerol …
T Cernak, NJ Gesmundo, K Dykstra, Y Yu, Z Wu, ZC Shi, P Vachal, ...
Journal of Medicinal Chemistry 60 (9), 3594-3605, 2017
842017
Computer-assisted design of selective imidazole inhibitors for cytochrome p450 enzymes
A Verras, ID Kuntz, PR Ortiz de Montellano
Journal of medicinal chemistry 47 (14), 3572-3579, 2004
622004
Cytochrome P450 active site plasticity: attenuation of imidazole binding in cytochrome P450cam by an L244A mutation
A Verras, A Alian, PRO Montellano
Protein Engineering, Design and Selection 19 (11), 491-496, 2006
372006
QSAR Prediction of Passive Permeability in the LLC‐PK1 Cell Line: Trends in Molecular Properties and Cross‐Prediction of Caco‐2 Permeabilities
EC Sherer, A Verras, M Madeira, WK Hagmann, RP Sheridan, D Roberts, ...
Molecular informatics 31 (3‐4), 231-245, 2012
342012
Discovery of Chromane Propionic Acid Analogues as Selective Agonists of GPR120 with in Vivo Activity in Rodents
GL Adams, F Velazquez, C Jayne, U Shah, S Miao, ER Ashley, M Madeira, ...
ACS Medicinal Chemistry Letters 8 (1), 96-101, 2017
332017
Discovery and pharmacology of a novel class of diacylglycerol acyltransferase 2 inhibitors
JE Imbriglio, DM Shen, R Liang, K Marby, M You, HW Youm, Z Feng, ...
Journal of medicinal chemistry 58 (23), 9345-9353, 2015
292015
Structural basis for isoform-specific inhibition of human CTPS1
EM Lynch, MA DiMattia, S Albanese, GCP van Zundert, JM Hansen, ...
Proceedings of the National Academy of Sciences 118 (40), e2107968118, 2021
282021
Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys
SB Hoyt, MK Park, C London, Y Xiong, J Tata, DJ Bennett, A Cooke, J Cai, ...
ACS medicinal chemistry letters 6 (5), 573-578, 2015
272015
MAIP: a web service for predicting blood‐stage malaria inhibitors
N Bosc, E Felix, R Arcila, D Mendez, MR Saunders, DVS Green, ...
Journal of Cheminformatics 13, 1-14, 2021
242021
Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension
SB Hoyt, J Taylor, C London, A Ali, F Ujjainwalla, J Tata, M Struthers, ...
Bioorganic & Medicinal Chemistry Letters 27 (11), 2384-2388, 2017
222017
Informing the selection of screening hit series with in silico absorption, distribution, metabolism, excretion, and toxicity profiles: miniperspective
JM Sanders, DC Beshore, JC Culberson, JI Fells, JE Imbriglio, ...
Journal of medicinal chemistry 60 (16), 6771-6780, 2017
192017
Discovery of triazole CYP11B2 inhibitors with in vivo activity in rhesus monkeys
SB Hoyt, W Petrilli, C London, GB Liang, J Tata, Q Hu, L Yin, ...
ACS Medicinal Chemistry Letters 6 (8), 861-865, 2015
192015
Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitors
HC Shen, FX Ding, C Zhou, Y Xiong, A Verras, RM Chabin, S Xu, X Tong, ...
Bioorganic & medicinal chemistry letters 21 (5), 1299-1305, 2011
192011
Shared consensus machine learning models for predicting blood stage malaria inhibition
A Verras, CL Waller, P Gedeck, DVS Green, T Kogej, A Raichurkar, ...
Journal of chemical information and modeling 57 (3), 445-453, 2017
182017
Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidase
X Zhao, K Southwick, HL Cardasis, Y Du, ME Lassman, D Xie, ...
Proteomics 10 (15), 2882-2886, 2010
182010
Discovery of spirocyclic aldosterone synthase inhibitors as potential treatments for resistant hypertension
WL Petrilli, SB Hoyt, C London, D McMasters, A Verras, M Struthers, ...
ACS medicinal chemistry letters 8 (1), 128-132, 2017
172017
The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors
TH Graham, HC Shen, W Liu, Y Xiong, A Verras, K Bleasby, UR Bhatt, ...
Bioorganic & medicinal chemistry letters 22 (1), 658-665, 2012
162012
Pyrazoles as non-classical bioisosteres in prolylcarboxypeptidase (PrCP) inhibitors
TH Graham, M Shu, A Verras, Q Chen, M Garcia-Calvo, X Li, JM Lisnock, ...
Bioorganic & Medicinal Chemistry Letters 24 (7), 1657-1660, 2014
152014
系统目前无法执行此操作,请稍后再试。
文章 1–20